A Phase 1b Study of NC410 in Combination with Pembrolizumab in Immune Checkpoint Inhibitor (ICI) Naïve, and Refractory Microsatellite Stable (mss)/microsatellite Instability-Low (MSI-L) Colorectal Cancer (CRC) and Ovarian Cancer.
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined